These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24960544)

  • 1. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
    Alshayeb H; Showkat A; Wall BM; Gyamlani GG; David V; Quarles LD
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1830-7. PubMed ID: 24960544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
    Stubbs JR; Zhang S; Friedman PA; Nolin TD
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on vitamin D metabolism in the very elderly.
    Van Pottelbergh G; Matheï C; Vaes B; Adriaensen W; Gruson D; Degryse JM
    J Nutr Health Aging; 2013 Feb; 17(2):107-11. PubMed ID: 23364486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study.
    Cipriani C; Romagnoli E; Scillitani A; Chiodini I; Clerico R; Carnevale V; Mascia ML; Battista C; Viti R; Pileri M; Eller-Vainicher C; Minisola S
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4771-7. PubMed ID: 20660032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
    Massart A; Debelle FD; Racapé J; Gervy C; Husson C; Dhaene M; Wissing KM; Nortier JL
    Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
    Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects.
    Okazaki R; Sugimoto T; Kaji H; Fujii Y; Shiraki M; Inoue D; Endo I; Okano T; Hirota T; Kurahashi I; Matsumoto T
    J Bone Miner Metab; 2011 Jan; 29(1):103-10. PubMed ID: 20567864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.
    Garcia-Lopes MG; Pillar R; Kamimura MA; Rocha LA; Canziani ME; Carvalho AB; Cuppari L
    Ann Nutr Metab; 2012; 61(1):74-82. PubMed ID: 22889840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
    Chitalia N; Ismail T; Tooth L; Boa F; Hampson G; Goldsmith D; Kaski JC; Banerjee D
    PLoS One; 2014; 9(3):e91363. PubMed ID: 24646518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis.
    Li CH; Tang X; Wasnik S; Wang X; Zhang J; Xu Y; Lau KW; Nguyen HB; Baylink DJ
    BMC Infect Dis; 2019 Dec; 19(1):1020. PubMed ID: 31791247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
    Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K
    BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m².
    Nakatani S; Nakatani A; Tsugawa N; Yamada S; Mori K; Imanishi Y; Ishimura E; Okano T; Inaba M
    Nephron; 2015; 130(2):119-26. PubMed ID: 26068724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
    Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
    Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 24,25-dihydroxyvitamin D
    Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
    Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.